|
UBE2D3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.762900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.886160E-01 |
| Normal-vs-Stage2 |
5.852400E-01 |
| Normal-vs-Stage3 |
4.23699999996252E-06 |
| Normal-vs-Stage4 |
1.19399999998215E-07 |
| Stage1-vs-Stage2 |
8.557000E-01 |
| Stage1-vs-Stage3 |
4.48910000000469E-05 |
| Stage1-vs-Stage4 |
2.12280000000398E-06 |
| Stage2-vs-Stage3 |
8.978100E-03 |
| Stage2-vs-Stage4 |
2.918400E-03 |
| Stage3-vs-Stage4 |
4.489200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.576900E-03 |
| Normal-vs-AfricanAmerican |
1.993230E-04 |
| Normal-vs-Asian |
4.584000E-01 |
| Caucasian-vs-AfricanAmerican |
1.086630E-01 |
| Caucasian-vs-Asian |
7.729600E-01 |
| AfricanAmerican-vs-Asian |
3.238200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.92139999999941E-05 |
| Normal-vs-Female |
1.137560E-01 |
| Male-vs-Female |
1.712060E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.970100E-04 |
| Normal-vs-Age(41-60Yrs) |
2.119900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.997500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.343600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.378590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.259400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.685800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.636800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.976800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.205400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.092600E-01 |
| Normal-vs-Grade 2 |
5.337400E-01 |
| Normal-vs-Grade 3 |
1.51807999999587E-05 |
| Normal-vs-Grade 4 |
5.65769986415887E-10 |
| Grade 1-vs-Grade 2 |
4.419600E-01 |
| Grade 1-vs-Grade 3 |
9.676300E-03 |
| Grade 1-vs-Grade 4 |
7.59410000000793E-05 |
| Grade 2-vs-Grade 3 |
5.81809999999905E-05 |
| Grade 2-vs-Grade 4 |
2.04630001832129E-09 |
| Grade 3-vs-Grade 4 |
2.918500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.782000E-01 |
| Normal-vs-ccB subtype |
4.28709999999999E-06 |
| ccA subtype-vs-ccB subtype |
8.27739999875732E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.314300E-02 |
| Normal-vs-N1 |
1.423670E-02 |
| N0-vs-N1 |
8.626300E-02 |
|
|
